Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$93.96K
2,035 shares @ $46.17
Traded
Nov 3, 2026
Filed
Nov 3, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Alkermes Inc
ALKS
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
36 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Nov 3, 2026 Same-day filing | Sale Nov 3, 2026 | $93.96K Filed shares x price | SEC Form 4 View filing | |
| Reed Joshua SVP, Chief Financial Officer | Oct 9, 2026 1-day lag | Exercise Oct 8, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Reed Joshua SVP, Chief Financial Officer | Oct 9, 2026 1-day lag | Disposition Oct 8, 2026 | $163.21K Filed shares x price | SEC Form 4 View filing | |
| Reed Joshua SVP, Chief Financial Officer | Oct 9, 2026 1-day lag | Exercise Oct 8, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Whitaker Anne Clem Director | Oct 9, 2026 2-day lag | Award Oct 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Whitaker Anne Clem Director | Oct 9, 2026 2-day lag | Award Oct 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Oct 2, 2026 Same-day filing | Sale Oct 2, 2026 | $83.46K Filed shares x price | SEC Form 4 View filing | |
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sep 3, 2026 Same-day filing | Sale Sep 3, 2026 | $97.65K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Sep 1, 2026 Same-day filing | Exercise Sep 1, 2026 | $122.95K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Sep 1, 2026 Same-day filing | Sale Sep 1, 2026 | $422.87K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Sep 1, 2026 Same-day filing | Exercise Sep 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Nichols Christian Todd SVP, Chief Commercial Officer | Aug 17, 2026 Same-day filing | Sale Aug 17, 2026 | $339.97K Filed shares x price | SEC Form 4 View filing | |
| Nichols Christian Todd SVP, Chief Commercial Officer | Aug 17, 2026 Same-day filing | Sale Aug 17, 2026 | $32.97K Filed shares x price | SEC Form 4 View filing | |
| Jackson Blair Curtis President & CEO, Alkermes PLC | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Jackson Blair Curtis President & CEO, Alkermes PLC | Aug 7, 2026 2-day lag | Award Aug 5, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $772K Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Sale Aug 3, 2026 | $2.24M Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $1.31M Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Snyderman Nancy Lynn Md Director | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $120.39K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $2.01K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Sale Aug 3, 2026 | $437.22K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | Aug 3, 2026 Same-day filing | Exercise Aug 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Aug 3, 2026 Same-day filing | Sale Aug 3, 2026 | $98.81K Filed shares x price | SEC Form 4 View filing | |
| Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Jul 6, 2026 Same-day filing | Sale Jul 6, 2026 | $109.9K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Jul 1, 2026 Same-day filing | Exercise Jul 1, 2026 | $96.7K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Jul 1, 2026 Same-day filing | Sale Jul 1, 2026 | $36.49K Filed shares x price | SEC Form 4 View filing | |
| Hopkinson Craig C. EVP R&d, Chief Medical Officer | Jul 1, 2026 Same-day filing | Exercise Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Reed Joshua
SVP, Chief Financial Officer
Exercise
Reported value range
Not reported
9,164 shares
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Reed Joshua
SVP, Chief Financial Officer
Disposition
Calculated transaction value
$163.21K
4,069 shares @ $40.11
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Reed Joshua
SVP, Chief Financial Officer
Exercise
Reported value range
Not reported
9,164 shares
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Whitaker Anne Clem
Director
Award
Calculated transaction value
$0
7,239 shares @ $0
Traded
Oct 7, 2026
Filed
Oct 9, 2026
Whitaker Anne Clem
Director
Award
Calculated transaction value
$0
17,998 shares @ $0
Traded
Oct 7, 2026
Filed
Oct 9, 2026
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$83.46K
2,034 shares @ $41.03
Traded
Oct 2, 2026
Filed
Oct 2, 2026
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$97.65K
2,034 shares @ $48.01
Traded
Sep 3, 2026
Filed
Sep 3, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Exercise
Calculated transaction value
$122.95K
5,000 shares @ $24.59
Traded
Sep 1, 2026
Filed
Sep 1, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Sale
Calculated transaction value
$422.87K
9,000 shares @ $46.99
Traded
Sep 1, 2026
Filed
Sep 1, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Sep 1, 2026
Filed
Sep 1, 2026
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale
Calculated transaction value
$339.97K
6,912 shares @ $49.19
Traded
Aug 17, 2026
Filed
Aug 17, 2026
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale
Calculated transaction value
$32.97K
664 shares @ $49.65
Traded
Aug 17, 2026
Filed
Aug 17, 2026
Jackson Blair Curtis
President & CEO, Alkermes PLC
Award
Calculated transaction value
$0
93,229 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Jackson Blair Curtis
President & CEO, Alkermes PLC
Award
Calculated transaction value
$0
124,305 shares @ $0
Traded
Aug 5, 2026
Filed
Aug 7, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$772K
16,524 shares @ $46.72
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Sale
Calculated transaction value
$2.24M
44,472 shares @ $50.35
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$1.31M
27,948 shares @ $46.72
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$0
16,524 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Snyderman Nancy Lynn Md
Director
Exercise
Calculated transaction value
$0
27,948 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$120.39K
4,896 shares @ $24.59
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$0
104 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$2.01K
104 shares @ $19.34
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale
Calculated transaction value
$437.22K
9,000 shares @ $48.58
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Exercise
Calculated transaction value
$0
4,896 shares @ $0
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$98.81K
2,034 shares @ $48.58
Traded
Aug 3, 2026
Filed
Aug 3, 2026
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale
Calculated transaction value
$109.9K
2,034 shares @ $54.03
Traded
Jul 6, 2026
Filed
Jul 6, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Exercise
Calculated transaction value
$96.7K
5,000 shares @ $19.34
Traded
Jul 1, 2026
Filed
Jul 1, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Sale
Calculated transaction value
$36.49K
700 shares @ $52.13
Traded
Jul 1, 2026
Filed
Jul 1, 2026
Hopkinson Craig C.
EVP R&d, Chief Medical Officer
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 1, 2026